ATXCO

ATXCo core asset is PAT-409, a Phase I ready autotaxin inhibitor for idiopathic pulmonary fibrosis (IPF).

#More

ATXCO

Industry:
Therapeutics

Status:
Active


More informations about "ATXCo"

ATXCo 2025 Company Profile: Valuation, Investors, Acquisition

What industry is ATXCo in? ATXCo’s primary industry is Biotechnology. Is ATXCo a private or public company? ATXCo is a Private company. What is ATXCo’s current revenue? The …See details»

ATXCo, Inc. Company Profile | San Diego, CA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ATXCo, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»

Anti-fibrosis Pipeline Expands for Blade After Buying …

Oct 1, 2019 “As Atxco evaluated opportunities for PAT-409, it became clear that Blade’s commitment to patients with fibrosis and best-in-class team provide an …See details»

Blade Therapeutics acquires ATXCo - 2019-09-25 - Crunchbase

Acquired Organization: ATXCo ATXCo core asset is PAT-409, a Phase I ready autotaxin inhibitor for idiopathic pulmonary fibrosis (IPF). Acquiring Organization: Blade Therapeutics Blade …See details»

ATXCo - Products, Competitors, Financials, Employees, …

ATXCo's core asset is PAT-409, a Phase I ready autotaxin inhibitor for idiopathic pulmonary fibrosis (IPF), NASH (nonalcoholic steatohepatitis), PBC (primary biliary cholangitis), …See details»

Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition …

Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409) By, Admin 27 September 2019 Blade Therapeutics, a biopharmaceutical …See details»

Blade Therapeutics Expands Anti-Fibrotic Pipeline With ... - BioSpace

Sep 25, 2019 Blade Therapeutics, a biopharmaceutical company advancing novel anti-fibrotic therapies, today announced the acquisition of ATXCo, Inc., including its core asset, PAT-409, …See details»

Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition …

27 Sep 2019; Admin; News Article; Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409) Blade Therapeutics, a …See details»

ATXCo, Inc.: Drug pipelines, Patents, Clinical trials - Synapse

Explore ATXCo, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news.See details»

ATXCo Stock Price, Funding, Valuation, Revenue & Financial …

See ATXCo funding rounds, investors, investments, exits and more. Evaluate their financials based on ATXCo's post-money valuation and revenue. ATXCo Stock Price, Funding, …See details»

Autoxin - Pharmaceutical Business review

Image: Blade Therapeutics has expanded its anti-fibrotic pipeline with acquisition of ATXCo. Photo: courtesy of rawpixel from Pixabay. Pharmaceutical Business review is using cookiesSee details»

ATXCo Management Team - CB Insights

Explore {ATXCo's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

ATXCo: Company in United States, North America - Sovereign …

ATXCo: Region: North America: Country: United States: Type: Company: ATXCo Contact Information. Address: 3030 Bunker Hill Street Suite 325 San Diego CA 92109 United States: Region: North America: Country: United States: Get News Stories Delivered to Your Inbox. Your Email: Join Today {{ title }} ...See details»

ATXCo, Inc.: 药物管线_专利_临床试验_投融营收

Jan 24, 2024 了解ATXCo, Inc.公司的药物管线,治疗领域,技术平台,以及它的2篇新闻。See details»

Crews battle fire at recycling facility on Jackson Road in Camden ...

3 days ago Atco, New Jersey fire prompts air quality concerns; residents encouraged to shelter in place 01:16. Officials are asking residents to shelter in place after a fire at a recycling facility …See details»

Corporate Structure - ATCO

Our companies are engaged in Structures & Logistics (workforce housing, innovative modular facilities, construction, site support services, and logistics and operations management); …See details»

Executive Committee - ATCO

Customers are free to purchase natural gas services or electricity services from a retailer of their choice. For a list of retailers, visit ucahelps.alberta.ca or call 310-4822 (toll free in Alberta). In …See details»

About Us - ATCO

Customers are free to purchase natural gas services or electricity services from a retailer of their choice. For a list of retailers, visit ucahelps.alberta.ca or call 310-4822 (toll free in Alberta). In …See details»

Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition …

Sep 25, 2019 Link to full release from Blade Blade Therapeutics, a biopharmaceutical company advancing novel anti-fibrotic therapies, today announced the acquisition of ATXCo, Inc., …See details»

Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition …

Sep 25, 2019 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Blade Therapeutics, a biopharmaceutical company advancing novel anti-fibrotic therapies, today announced the …See details»